Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Levetiracetam NDC 39328-511 by Patrin Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - levetiracetam 01
Figure 1 - levetiracetam 02
This text provides statistical data on the percentage of patients for Placebo and different doses of Levetiracetam (1000 mg/day and 3000 mg/day). It indicates that the results for Levetiracetam at 3000 mg/day are statistically significant compared to the placebo.*
Figure 2 - levetiracetam 03
This is a statistical table presenting percentages for different treatment groups. It compares the effectiveness of placebo, and two different doses of Levetiracetam (1000 mg/day and 2000 mg/day). The table indicates that there are statistically significant differences in effectiveness between the Levetiracetam groups and the placebo group.*
Figure 3 - levetiracetam 04
This text shows percentage values and statistics for a comparison between a placebo group (N=104) and a group taking 3000 mg/day of Levetiracetam (N=180). The data indicates a statistically significant difference between the two groups.*
Figure 4 - levetiracetam 05
This text provides a comparison of the percentages of patients in two groups - Placebo (N=97) and Levetiracotam (N=101). It indicates that there is a statistically significant difference between the two groups.*
Figure 5 - levetiracetam 06
This text provides percentages for two different groups (19.6% and 43.1%) and mentions that one group is statistically significant versus the placebo group. It also indicates the sample sizes for the placebo group (N=51) and levetiracetam group (N=58). The information seems to be related to a study or clinical trial comparing the effects of levetiracetam with a placebo.*
Figure 6 - levetiracetam 07
This text appears to be a representation of a clinical trial result table comparing the effects of a placebo (with 84 patients) and Levetiracetam (with 79 patients) on patients. The percentages likely indicate the effectiveness or outcomes for different groups, with a note mentioning statistical significance versus the placebo group. The specific results or measurements are not provided.*
PRINCIPAL DISPLAY PANEL - 5 mL Cup Label - levetiracetam 08
This text contains information about a medication: - Brand: Rx Ong, - Product: Levetiracetam - Form: Oral Solution, USP - Strength: 500 mg/5 mL - For institutional use only - NDC: 33325-511-05 - Manufacturer: Patrin Pharma - Expiry Date: YYYY/MM/DD This medication is an oral solution of Levetiracetam with a concentration of 500 mg per 5 mL. It is intended for institutional use only and is manufactured by Patrin Pharma.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.